In an aspect of the invention, a composition for making a patch for the transdermal delivery of tamsulosin is provided. The composition comprises (a) at least about 1 wt % tamsulosin or a pharmaceutically acceptable salt of tamsulosin, (b) at least about 40 wt % polyisobutylene adhesive or hydrophob
In an aspect of the invention, a composition for making a patch for the transdermal delivery of tamsulosin is provided. The composition comprises (a) at least about 1 wt % tamsulosin or a pharmaceutically acceptable salt of tamsulosin, (b) at least about 40 wt % polyisobutylene adhesive or hydrophobic synthetic rubber adhesive, (c) about 1-20 wt % of an aprotic solvent in which tamsulosin dissolves readily, (d) about 1-20 wt % of an unsaturated fatty acid or an alpha-hydroxy acid or a mixture of unsaturated fatty acids or alpha-hydroxy acids or of both unsaturated fatty acids and alpha-hydroxy acids, (e) a lipophilic permeation enhancer, and (f) a matrix modifier.
대표청구항▼
1. A composition for making a patch for the transdermal delivery of tamsulosin, the composition comprising (a) at least 1 wt % tamsulosin or a pharmaceutically acceptable salt of tamsulosin, (b) at least 40 wt % polyisobutylene adhesive or hydrophobic synthetic rubber adhesive, (c) about 1-20 wt % o
1. A composition for making a patch for the transdermal delivery of tamsulosin, the composition comprising (a) at least 1 wt % tamsulosin or a pharmaceutically acceptable salt of tamsulosin, (b) at least 40 wt % polyisobutylene adhesive or hydrophobic synthetic rubber adhesive, (c) about 1-20 wt % of an aprotic solvent in which tamsulosin dissolves, (d) about 1-20 wt % of an unsaturated fatty acid or an alpha-hydroxy acid or a mixture of unsaturated fatty acids or alpha-hydroxy acids or of both unsaturated fatty acids and alpha-hydroxy acids, (e) a lipophilic permeation enhancer, and (f) a matrix modifier. 2. The composition of claim 1, wherein at least a portion of the tamsulosin is present in the form of tamsulosin HCl. 3. The composition of claim 2, further comprising a neutralizing agent. 4. The composition of claim 3, wherein the neutralizing agent has a pKa equivalent to or higher than that of tamsulosin. 5. The composition of claim 3, wherein the neutralizing agent comprises an alkali hydroxide, an alkali salt, or an amine. 6. The composition of claim 5, wherein the neutralizing agent comprises sodium hydroxide or potassium hydroxide. 7. The composition of claim 5, wherein the neutralizing agent comprises an alkali salt selected from the group consisting of sodium carbonate, potassium carbonate, sodium silicate, and potassium silicate. 8. The composition of claim 4, wherein the neutralizing agent comprises substituted or non-substituted alkyl amines. 9. The composition of claim 8, wherein the neutralizing agent comprises ethanolamine and diethanolamine. 10. The composition of claim 3, wherein the neutralizing agent comprises sodium hydroxide. 11. The composition of claim 1, comprising at least 50 wt % polyisobutylene adhesive. 12. The composition of claim 1, comprising at least 50 wt % hydrophobic synthetic rubber adhesive. 13. The composition of claim 1, wherein the aprotic solvent is selected from the group consisting of dimethylacetamide, N-methylpyrrolidone, dimethylsulfoxide and combinations thereof. 14. The composition of claim 1, wherein the unsaturated fatty acid is a fatty acid with 11 to 21 carbons or a mixture of such fatty acids. 15. The composition of claim 1, wherein the unsaturated fatty acid comprises oleic acid, linoleic acid, or linolenic acid. 16. The composition of claim 1, wherein the alpha-hydroxy acid comprises an acid with 1 to 8 carbons with an alpha-hydroxyl group. 17. The composition of claim 1, wherein the alpha-hydroxy acid is selected from the group consisting of lactic acid, glycolic acid, malic, citric, alpha-hydroxy caprylic acid, alpha-hydroxybutyric acid and combinations thereof. 18. The composition of claim 1, wherein the lipophilic permeation enhancer is present at about 1-20 wt %. 19. The composition of claim 1, wherein the lipophilic permeation enhancer is selected from the group consisting of methyl laurate, propylene glycol monolaurate, glycerol monolaurate, glycerol monooleate, lauryl lactate, myristyl lactate and combinations thereof. 20. The composition of claim 1, wherein the matrix modifier is present at about 4-20 wt % of the composition. 21. The composition of claim 1, wherein the matrix modifier is selected from the group consisting of fumed silica, colloidal silicon dioxide, cross-linked polyvinylpyrrolidone, soluble polyvinylpyrrolidone, a cellulose derivative, polyacrylamide, polyacrylic acid, a polyacrylic acid salt, kaolin, bentonite and combinations thereof. 22. A patch comprising an adhesive matrix made by a process which comprises drying the composition of claim 1. 23. The patch of claim 22, wherein the adhesive matrix after said drying comprises at least 15 wt % liquid. 24. The patch of claim 22, wherein the adhesive matrix after drying has a coat weight between about 10 mg/cm2 and 50 mg/cm2. 25. The patch of claim 22, wherein the in vitro delivery range of tamsulosin is at least 1.7-12.7 μg/cm2 per hr. 26. The patch of claim 22, wherein the adhesive matrix further comprises a nonwoven material. 27. The patch of claim 22, which in use over a 24-hour period of time is non-irritating or no more than mildly irritating. 28. The patch of claim 22, wherein the patch maintains self-adhesion for at least 7 days when it is worn. 29. A method of manufacturing a transdermal drug-in-adhesive patch for delivery of tamsulosin, comprising the steps of (a) dissolving tamsulosin or a pharmaceutically acceptable salt of tamsulosin in an aprotic solvent, (b) combining the tamsulosin solution with a lipophilic permeation enhancer, an optional organic solvent, and an unsaturated fatty acid, (c) adding to the result of (b) a matrix modifier and homogenizing the resulting solution, (d) mixing the result of (c) with a polyisobutylene adhesive or hydrophobic synthetic rubber adhesive in a suitable solvent. 30. The method of claim 29, further comprising adding a neutralizing agent to the result of steps (a) or (b). 31. The method of claim 29, further comprising solvent casting the result of step (d). 32. The method of claim 29, resulting in a weight ratio of tamsulosin to the cast, dried matrix of at least 1 wt %. 33. The method of claim 29, where the aprotic solvent is selected from the group consisting of dimethylacetamide, N-methylpyrrolidone, dimethylsulfoxide and combinations thereof. 34. The method of claim 29, wherein the pharmaceutically acceptable salt of tamsulosin is tamsulosin hydrochloride. 35. A method of treating a urological condition, comprising administering to a patient suffering from or in danger of developing such a condition a transdermal patch comprising a tamsulosin-containing composition of claim 1. 36. A composition for making a patch for the transdermal delivery of an active agent which has poor solubility in an adhesive matrix, the composition comprising (a) at least 1 wt % the active agent or a pharmaceutically acceptable salt of the active agent, (b) at least 40 wt % polyisobutylene adhesive or hydrophobic synthetic rubber adhesive, (c) about 1-20 wt % of an aprotic solvent in which the active agent dissolves readily, (d) about 1-20 wt % of an unsaturated fatty acid or an alpha-hydroxy acid a mixture of unsaturated fatty acids or alpha-hydroxy acids or of both unsaturated fatty acids and alpha-hydroxy acids, (e) a lipophilic permeation enhancer, and (f) a matrix modifier. 37. A transdermal delivery system comprising tamsulosin or a pharmaceutically acceptable salt thereof and an alpha-hydroxy acid, wherein the molar ratio of alpha-hydroxy acid to tamsulosin is at least 0.05:1. 38. A transdermal delivery system comprising tamsulosin or a pharmaceutically acceptable salt thereof and DMSO, wherein the ratio of the cumulative delivery of tamsulosin to cumulative delivery of DMSO is at least 0.05 during the period from 72 to 120 hours, andat least 0.08 during the period from 120 to 168 hours. 39. The transdermal delivery system of claim 38, wherein the ratio of the cumulative delivery of tamsulosin to the cumulative delivery of DMSO is no more than about 0.15 in the first 72 hours,no more than about 0.38 in the first 120 hours, andno more than about 0.60 in the 168 hour period. 40. The composition of claim 1, wherein at least a portion of the tamsulosin is present in the form of tamsulosin free base.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (250)
Parker, Hsing-Yeh; Merritt, Richard Foster; Fu, Zhenwen; Ibbitson, Scott Alan; Gore, Robert Howard; Wolfersberger, Martha Alice Harbaugh, Acrylic polymer compositions with crystalline side chains and processes for their preparation.
Schiraldi Michael T. (East Brunswick NJ) Perl Martin M. (Brooklyn NY) Rubin Howard (Rockaway NJ), Bioadhesive extruded film for intra-oral drug delivery and process.
Anderson John McCune (16 Torgrange Holywood ; County Down ; BT18 ONG ; Northern Ireland GBX) McAdams Eric Thomas (Ormsdale ; 52 Cable Road Whitehead ; County Antrim ; Northern Ireland BT38 9 PZ GBX) , Biomedical electrode device.
Arraudeau Jean-Pierre (Paris FRX) Patraud Jeanne (Paris FRX) Le Gall Louis (Bures-sur-Yvette FRX), Composition based on cationic polymers, anionic polymers and waxes for use in cosmetics.
Kulichikhin,Valery G.; Parandoosh,Shoreh; Feldstein,Mikhail M.; Antonov,Sergey; Cleary,Gary W., Composition for cushions, wound dressings and other skin-contacting products.
Kulichikhin,Valery G.; Parandoosh,Shoreh; Feldstein,Mikhail M.; Antonov,Sergey; Cleary,Gary W., Composition for cushions, wounds dressings and other skin-contacting products.
Takoh Noboru,JPX ; Kondo Masahiro,JPX ; Inoue Hiroshi,JPX, Composition used for hydrophilization and method for hydrophilization using said composition.
Kanios David P. ; Gentile Joseph A. ; Mantelle Juan A. ; Sablotsky Steven, Compositions and methods for topical administration of pharmaceutically active agents.
Bloom Roberta C. (Huntington CT) Deckner George E. (Cincinnati OH), Compositions for topical delivery of drugs comprising a mixture of high and low HLB surfactants and alkoxylated ether.
Magnus, Philip D.; Payne, Andrew H., Conversion of α,β-unsaturated ketones and α,β-unsaturated esters into α-hydroxy ketones and α-hydroxy esters using Mn(III) catalyst, phenylsilane and dioxygen.
Lee Eun Soo (Redwood City CA) Theeuwes Felix (Los Altos Hills CA) Wong S. L. Patrick (Hayward CA) Yum Su Il (Los Altos CA) Zaffaroni Alejandro (Atherton CA), Delayed onset transdermal delivery device.
Sagel Paul A. ; Dirksing Robert S. ; Rohman Frederick J., Delivery system for a tooth whitener using a strip of material having low flexural stiffness.
Sagel Paul Albert ; Dirksing Robert Stanley ; Rohman Frederick James, Delivery system for a tooth whitener using a strip of material having low flexural stiffness.
Dirksing Robert S. ; Sagel Paul A. ; Tweddell ; III Richard, Delivery system for an oral care substance using a permanently deformable strip of material.
Sagel Paul A. ; Dirksing Robert S. ; Rohman Frederick J., Delivery system for an oral care substance using a strip of material having low flexural stiffness.
Sagel Paul Albert ; Dirksing Robert Stanley ; Rohman Frederick James ; Majeti Satyanarayana ; Reno Elizabeth Ann, Delivery system for an oral care substance using a strip of material having low flexural stiffness.
Curtis John (Bloomsbury NJ) Nahoo Salim (Piscataway NJ) Prencipe Michael (E. Windsor NJ), Dental material and method for applying preventative and therapeutic agents.
Chang Yunik (Toms River NJ) Patel Dinesh C. (Murray UT) Ebert Charles D. (Salt Lake City UT), Device for administering an active agent to the skin or mucosa.
Chang Yunik (Toms River NJ) Patel Dinesh C. (Murray UT) Ebert Charles D. (Salt Lake City UT), Device for administering an active agent to the skin or mucosa.
Chheang, Theary; Hine, Andrew M.; Muggli, Mark W.; Noe, Susan C.; Sanft, Patricia M.; Schultz, William J.; Taylor, Robert D.; Tead, Stanley F., Devices, compositions, and methods incorporating adhesives whose performance is enhanced by organophilic clay constituents.
Gyory J. Richard (Los Altos CA) Haak Ronald P. (Cupertino CA) Theeuwes Felix (Los Altos CA) Lew Patrick J. (Mountain View CA), Electrotransport adhesive.
Tseng Susan Y. (Staten Island NY) Wolf Philip F. (Bridgewater NJ) Burlant William J. (Wayne NJ), Films and extrusions of cured crosslinked vinyl lactam polymer and method of preparation.
Roreger Michael (Neuwied DEX) Herrmann Fritz (Neuwied DEX) Hoffmann Hans-Rainer (Neuwied DEX) List Harald (Neuwied DEX), Flexible, hydrophilic gel film, the process for its production and the use of it.
Singh, Parminder; Faasse, Adrian; Cleary, Gary W.; Mudumba, Sri; Feldstein, Mikhail M.; Bairamov, Danir R., Hydrogel compositions with an erodible backing member.
Holmblad Carolann M. (Cambridge MN) Bergstrom Joan M. (Minneapolis MN) Bartlett Terese A. (Circle Pines MN), Hydrophilic pressure sensitive adhesive for topical administration of hydrophobic drugs.
Jevne Allan H. (Anoka MN) Vegoe Brett R. (Brooklyn Park MN) Holmblad Carolann M. (Cambridge MN) Cahalan Patrick T. (Champlin MN), Hydrophilic pressure sensitive biomedical adhesive composition.
Nielsen Kent E.,CAX ; Li Kai,CAX ; Kantner Steven S. ; Koski Nancy L. ; Everaerts Albert I., Ionically conductive adhesives prepared from zwitterionic materials and medical devices using such adhesives.
Gyory J. Richard (Los Altos CA) Haak Ronald P. (Cupertino CA) Theeuwes Felix (Los Altos CA) Lew Patrick J. (Mountain View CA), Iontophoretic device incorporating an electrotransport adhesive.
Samour Carlos ; Krauser Scott F., Lipophilic and amphiphilic or hydrophilic film-forming polymer compositions, and use thereof in topical agent delivery.
Broberg Berndt F. J. (Sdertlje SEX) Evers Hans C. A. (Sdertlje SEX), Local anesthetic mixture for topical application and method for obtaining local anesthesia.
Broberg, Berndt F. J.; Evers, Hans C. A., Local anesthetic mixture for topical application, process for its preparation, as well as method for obtaining local anesthesia.
Itoh Steven K. (Cottage Grove MN) Dietz Timothy M. (St. Paul MN) Uy Rosa (St. Paul MN), Low impedance pressure sensitive adhesive composition and biomedical electrodes using same.
Yeo, Woon-Sung; Yun, Yeo-Han, Method for forming an information recording medium having information on spare area, and method and apparatus for recording/reproducing data to/from the medium.
Barton James Bradbury ; Shari Joy Soper ; Joseph Robert Kaczvinsky, Jr. ; Dorothy Limerick Bailey ; Celeste Dawn Gale, Method for regulating hair growth.
Gleich Gerald J. (Rochester MN) Ohnishi Tsukasa (Tokyo JPX) Hunt Loren W. (Rochester MN), Method for the treatment of eosinophil-associated diseases by administration of topical anesthetics.
Hofmann Gunter A. ; Dev Sukhendu B. ; Dimmer Steven C. ; Levatter Jeffrey I. ; Nanda Gurvinder S., Method of Selectively applying needle array configurations.
Moro, Daniel G.; Callahan, Howard; Nowotnik, David, Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds.
Tucker Mark J. (Round Steps ; High Street Stow-on-the-Wold ; Gloucester GL54 1DL GBX) Tucker Mark R. (P.O. Box 23530 Bahrain BHX), Occlusive body for administering a physiologically active substance.
Patel Dinesh C. (Murray UT) Chang Yunik (Lakewood NJ), Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols.
Lerner E. Itzhak,ILX ; Rosenberger Vered,ILX ; Flashner Moshe,ILX, Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity.
Dietz Timothy M. (St. Paul MN) Lu Ying-Yuh (Woodbury MN) Uy Rosa (St. Paul MN) Young Chung I. (Roseville MN), Polymerized microemulsion pressure sensitive adhesive compositions and methods of preparing and using same.
Feldstein, Mikhail M.; Plate, Nicolai A.; Chalykh, Anatoly E.; Cleary, Gary W., Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties.
Therriault Donald J. (Lowell MA) Temin Samuel C. (Needham MA) Shah Kishore R. (Bridgewater NJ), Pressure-sensitive hydrophilic laminate structures for use in wound dressing, transdermal and topical drug delivery.
Duan Daniel C. (St. Paul MN) Asmus Robert A. (Township of Hudson ; County of St. Croix WI) Dietz Timothy M. (St. Paul MN) Uy Rosa (St. Paul MN) Benson ; Jr. Olester (Woodbury MN), Pressure-sensitive poly(n-vinyl lactam) adhesive composition and method for producing and using same.
Plate Nicolai A.,RUX ; Valuev Lev I.,RUX ; Uzhinova Lubov D.,RUX ; Sinani Vladimir A.,RUX, Process for preparing biologically compatible polymers and their use in medical devices.
Pfister William R. (Bay City MI) Wilson Jeniffer M. (Saginaw MI), Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices.
Lee Eun Soo (Redwood City CA) Nedberge Diane E. (Los Altos CA) Yum Su Il (Los Altos CA), Skin permeation enhancer compositions using glycerol monolinoleate.
Chiang Chia-Ming (Foster City CA) Cleary Gary W. (San Mateo CA), Skin permeation enhancer compositions, and methods and transdermal systems associated therewith.
Miranda Jesus (Miami FL) Sablotsky Steven (Miami FL), Solubility parameter based drug delivery system and method for altering drug saturation concentration.
Wagner Julie Ann ; Zukowski Joseph Michael ; Robinson Larry Richard ; Deckner George Endel ; Rinaldi Marie Antoinette ; Szymanski Victoria Claire, Stable topical compositions.
Jones, Todd K.; Goldman, Mark E.; Pooley, Charlotte L. F.; Winn, David T.; Edwards, James P.; West, Sarah J.; Tegley, Christopher M.; Zhi, Lin; Hamann, Lawrence G.; Farmer, Luc J.; Davis, Robert L., Steroid receptor modulator compounds and methods.
Enscore David J. (Sunnyvale CA) Campbell Patricia S. (Palo Alto CA) Osborne James L. (Mountain View CA) Smart Melinda K. (Sunnyvale CA) Yum Su I. (Los Altos CA), Subsaturated transdermal therapeutic system having improved release characteristics.
Enscore David J. (Sunnyvale CA) Campbell Patricia S. (Palo Alto CA) Osborne James L. (Mountain View CA) Smart Melinda K. (Sunnyvale CA) Yum Su I. (Los Altos CA), Subsaturated transdermal therapeutic system having improved release characteristics.
Turner Josephine S. (Kettleby CAX) Murray D. Gary (Willowdale CAX) Zuccolin John D. (Stouffville CAX) Li Ruey S. (Thornhill CAX), Substance transfer system for topical application.
Gale Robert M. (Los Altos CA) Nedberge Diane E. (Los Altos CA) Atkinson Linda E. (Portola Valley CA), Transdermal contraceptive formulations, methods and devices.
Min Dong Son,KRX ; Um Kee An,KRX ; Kim Yong Soo,KRX ; Park Pyeong Uk,KRX ; Kim Key Hyup,KRX ; Yang Ho Seung,KRX ; Jeong Hey Soon,KRX ; Park Mi Young,KRX, Transdermal delivery matrix for piroxicam.
Ebert Charles D. (Salt Lake City UT) Heiber Werner (Salt Lake City UT) Good William R. (Salt Lake City UT) Venkateshwaran Srinivasan (Salt Lake City UT), Transdermal delivery system with adhesive overlay and peel seal disc.
Chiang Chia-Ming (Foster City CA) Colley Kenneth J. (Washington DC) Cleary Gary W. (San Mateo CA), Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset.
Ma Xinghang ; Audett Jay ; Soni Pravin L. ; Singh Noel ; Bailey Susan E., Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use.
Chien Yie W. (North Brunswick NJ) Chien Te-Yen (Piscataway NJ) Huang Yih-Chain (Piscataway NJ), Transdermal estrogen/progestin dosage unit, system and process.
Jona Janan ; Audett Jay ; Singh Noel, Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen.
Jona Janan ; Audett Jay ; Singh Noel, Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen.
Horstmann Michael (Neuwied DEX) Herrmann Fritz (Neuwied DEX), Transdermal therapeutic system exhibiting an increased active substance flow and process for the production thereof.
Kleinsorgen Reinhard v.,DEX ; Kleinsorgen Britta v.,DEX, Transdermal therapeutic system with small application-area thickness and great flexibility, and production process.
Jan A. Orlowski ; David V. Butler, Two-part composition for high efficacy teeth whitening comprising a mixture of peroxides and/or percarbonates of metals.
Dietz Timothy M. (St. Paul MN) Asmus Robert A. (Hudson WI) Uy Rosa (St. Paul MN), Two-phase composites of ionically-conductive pressure-sensitive adhesive, biomedical electrodes using the composites, an.
Login Robert B. (Oakland NJ) Merianos John J. (Middletown NJ) Biss Russell B. (Paramus NJ) Garelick Paul (South Plainfield NJ), Urea-hydrogen peroxide-polyvinylpyrrolidone.
Login Robert B. (Oakland NJ) Merianos John J. (Middletown NJ) Biss Russell B. (Wayne NJ) Garelick Paul (South Plainfield NJ), Urea-hydrogen peroxide-polyvinylpyrrolidone process.
Kantner Steven S. ; Kuester Wilhelm,DEX, Use of pendant free-radically polymerizable moieties with polar polymers to prepare hydrophilic pressure sensitive adhes.
Gaglio Thomas J. (4421 La Paloma Santa Barbara CA 93105) Santoriello Luigi (3463 State St. ; #359 Santa Barbara CA 93105), Viscous fluid dispensing apparatus.
Kim Son Nguyen,DEX ; Sanner Axel,DEX ; Hossel Peter,DEX ; Schehlmann Volker,DEX, Water-soluble or water-dispersible graft copolymers based on a polyvinyllactam, their preparation and use.
Biegajski James E. (Foster City CA) Venkatraman Subbu S. (Palo Alto CA) Scott Ann M. (Mountain View CA), Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavi.
Beier Helmut (Darmstadt DEX) Petereit Hans-Ulrich (Darmstadt DEX) Bergmann Gunter (Hanau DEX), Water-soluble pressure-sensitive skin adhesive, its use, and agents provided with it.
Singh, Parminder; Cleary, Gary W.; Mudumba, Sri; Feldstein, Mikhail M.; Bairamov, Danir R., Hydrogel compositions demonstrating phase separation on contact with aqueous media.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.